Sabby Management’s Cellectar Biosciences, Inc. CLRBW Stock Holding History

Sabby Management’s Portfolio CLRBW Stock Details CLRBW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-201,889	Closed	-$85K	–	352
2016 Q4	$85K	Sell	201,889 -26,899	-12%	-$6.06K	﹤0.01%	271
2016 Q3	$188K	Sell	228,788 -1,225	-0.5%	-$392	0.01%	274
2016 Q2	$219K	Buy	230,013 +164,651	+252%	+$100K	0.01%	243
2016 Q1	$47K	Buy	+65,362	New	+$198K	﹤0.01%	283

Other funds holding CLRBW

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Sabby Management's CLRBW Position: Q1 2017 in Review

Sabby Management sold out of Cellectar Biosciences, Inc. (CLRBW) in Q1 2017, closing a stake of 201,889 shares — an estimated $85K sold.

Sabby Management first reported a position in CLRBW in Q1 2016 and held it in 4 quarters. The position peaked at $219K in Q2 2016. 3 funds tracked by Wall St. Rank hold CLRBW as of Q1 2017.

Sabby Management reported no remaining Cellectar Biosciences, Inc. position as of Q1 2017 after selling out during the quarter.
Sabby Management sold 201,889 Cellectar Biosciences, Inc. shares in Q1 2017, an estimated $85K.
Sabby Management first reported a position in Cellectar Biosciences, Inc. in Q1 2016 and held it in 4 quarters.
Sabby Management's Cellectar Biosciences, Inc. position peaked at $219K in Q2 2016.
3 funds tracked by Wall St. Rank held Cellectar Biosciences, Inc. as of Q1 2017.

Based on Sabby Management's 13F filing for Q1 2017, filed 15 May 2017.